HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Consumer United States Strategy

Interview: Fugate Attracted By UrgentRx Focus On Branding, Unique Positioning

This article was originally published in The Tan Sheet

  • News

Executive Summary

Ron Fugate sees UrgentRx not only using some of the strongest marketing strategies he’s known for building a successful consumer health care product brand, but also making headway in new areas important to driving sales for new products.

You may also be interested in...



Alacer Sale Underscores Value-Add Of Best Practices

Best practices help establish a firm’s appeal as an acquisition target, illustrated by the case of Pfizer’s acquisition of Emergen-C maker Alacer.`

New Products In Brief

I AM opens doors, launches liquids

NBTY Expands Into Mass Market With Zila Acquisition

NBTY is looking to use Ester-C brand recognition and loyalty to gain traction in the mass retail market

Table

View full table

Topics

Related Companies

Tags:
Consumer United States Strategy
Latest Headlines

Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation

Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD

Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories

‘Meaningful Revenues’ In 2023 Mark Strategic Milestone As Futura Looks To Future

See All
UsernamePublicRestriction

Register

RS139633

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By